サマリー

インフルエンザワクチンの世界市場 2022-2026 年
Technavioはインフルエンザワクチン市場を監視しており、2022-2026年の間に25億6000万ドルの成長が見込まれ、予測期間中にCAGR 8.66%で加速しています。当レポートでは、インフルエンザワクチン市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、インフルエンザの流行と発生率の増加、インフルエンザワクチン接種に関する意識の高まり、予防接種プログラムや研究活動の開始によって牽引されています。
インフルエンザワクチン市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioのインフルエンザワクチン市場は、以下のようにセグメント化されています。
タイプ別
- 弱毒性インフルエンザ生ワクチン
- 遺伝子組換えインフルエンザワクチン
地域別
- 北アメリカ
- ヨーロッパ
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるインフルエンザワクチン市場の成長を促進する主な理由の1つとして、再接種ニーズが挙げられています。また、インフルエンザウイルスの遺伝子特性研究の急増や世界的な旅行者数の増加も、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。インフルエンザワクチン市場に関する当レポートの対象領域は以下の通りです。
- インフルエンザワクチン市場のサイジング
- インフルエンザワクチン市場予測
- インフルエンザワクチン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Altimmune Inc.、AstraZeneca Plc、Baxter International Inc,BioDiem、BiondVax Pharmaceuticals Ltd.、CSL Ltd.、Emergent BioSolutions Inc.、F. Hoffmann La Roche Ltd.、FluGen Inc.、グラクソ・スミスクライン Plc、Medicago Inc、Novavax Inc、Pfizer Inc、Sanofi、Shijiazhuang Yiling Pharmaceutical Co Ltd. 、SK Chemicals Co.Ltd.、Vaccitech Plc、Vaxart Inc.、Vaxine Pty Ltd.、およびVisterra Inc.が含まれます。また、インフルエンザワクチン市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/influenza-vaccine-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Live attenuated influenza vaccines - Market size and forecast 2021-2026
o Exhibit 28: Chart on Live attenuated influenza vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Live attenuated influenza vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Live attenuated influenza vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Live attenuated influenza vaccines - Year-over-year growth 2021-2026 (%)
o 5.4 Recombinant influenza vaccines - Market size and forecast 2021-2026
o Exhibit 32: Chart on Recombinant influenza vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Recombinant influenza vaccines - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Recombinant influenza vaccines - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Recombinant influenza vaccines - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Altimmune Inc.
o Exhibit 85: Altimmune Inc. - Overview
o Exhibit 86: Altimmune Inc. - Business segments
o Exhibit 87: Altimmune Inc. - Key news
o Exhibit 88: Altimmune Inc. - Key offerings
o Exhibit 89: Altimmune Inc. - Segment focus
o 10.4 AstraZeneca Plc
o Exhibit 90: AstraZeneca Plc - Overview
o Exhibit 91: AstraZeneca Plc - Product / Service
o Exhibit 92: AstraZeneca Plc - Key news
o Exhibit 93: AstraZeneca Plc - Key offerings
o 10.5 Baxter International Inc.
o Exhibit 94: Baxter International Inc. - Overview
o Exhibit 95: Baxter International Inc. - Business segments
o Exhibit 96: Baxter International Inc. - Key news
o Exhibit 97: Baxter International Inc. - Key offerings
o Exhibit 98: Baxter International Inc. - Segment focus
o 10.6 BiondVax Pharmaceuticals Ltd.
o Exhibit 99: BiondVax Pharmaceuticals Ltd. - Overview
o Exhibit 100: BiondVax Pharmaceuticals Ltd. - Product / Service
o Exhibit 101: BiondVax Pharmaceuticals Ltd. - Key offerings
o 10.7 CSL Ltd.
o Exhibit 102: CSL Ltd. - Overview
o Exhibit 103: CSL Ltd. - Business segments
o Exhibit 104: CSL Ltd. - Key news
o Exhibit 105: CSL Ltd. - Key offerings
o Exhibit 106: CSL Ltd. - Segment focus
o 10.8 FluGen Inc.
o Exhibit 107: FluGen Inc. - Overview
o Exhibit 108: FluGen Inc. - Product / Service
o Exhibit 109: FluGen Inc. - Key offerings
o 10.9 GlaxoSmithKline Plc
o Exhibit 110: GlaxoSmithKline Plc - Overview
o Exhibit 111: GlaxoSmithKline Plc - Business segments
o Exhibit 112: GlaxoSmithKline Plc - Key news
o Exhibit 113: GlaxoSmithKline Plc - Key offerings
o Exhibit 114: GlaxoSmithKline Plc - Segment focus
o 10.10 Medicago Inc
o Exhibit 115: Medicago Inc - Overview
o Exhibit 116: Medicago Inc - Product / Service
o Exhibit 117: Medicago Inc - Key offerings
o 10.11 Novavax Inc.
o Exhibit 118: Novavax Inc. - Overview
o Exhibit 119: Novavax Inc. - Product / Service
o Exhibit 120: Novavax Inc. - Key offerings
o 10.12 Sanofi
o Exhibit 121: Sanofi - Overview
o Exhibit 122: Sanofi - Business segments
o Exhibit 123: Sanofi - Key news
o Exhibit 124: Sanofi - Key offerings
o Exhibit 125: Sanofi - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Live attenuated influenza vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Live attenuated influenza vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Live attenuated influenza vaccines - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Live attenuated influenza vaccines - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Recombinant influenza vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Recombinant influenza vaccines - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Recombinant influenza vaccines - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Recombinant influenza vaccines - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Altimmune Inc. - Overview
Exhibits86: Altimmune Inc. - Business segments
Exhibits87: Altimmune Inc. - Key news
Exhibits88: Altimmune Inc. - Key offerings
Exhibits89: Altimmune Inc. - Segment focus
Exhibits90: AstraZeneca Plc - Overview
Exhibits91: AstraZeneca Plc - Product / Service
Exhibits92: AstraZeneca Plc - Key news
Exhibits93: AstraZeneca Plc - Key offerings
Exhibits94: Baxter International Inc. - Overview
Exhibits95: Baxter International Inc. - Business segments
Exhibits96: Baxter International Inc. - Key news
Exhibits97: Baxter International Inc. - Key offerings
Exhibits98: Baxter International Inc. - Segment focus
Exhibits99: BiondVax Pharmaceuticals Ltd. - Overview
Exhibits100: BiondVax Pharmaceuticals Ltd. - Product / Service
Exhibits101: BiondVax Pharmaceuticals Ltd. - Key offerings
Exhibits102: CSL Ltd. - Overview
Exhibits103: CSL Ltd. - Business segments
Exhibits104: CSL Ltd. - Key news
Exhibits105: CSL Ltd. - Key offerings
Exhibits106: CSL Ltd. - Segment focus
Exhibits107: FluGen Inc. - Overview
Exhibits108: FluGen Inc. - Product / Service
Exhibits109: FluGen Inc. - Key offerings
Exhibits110: GlaxoSmithKline Plc - Overview
Exhibits111: GlaxoSmithKline Plc - Business segments
Exhibits112: GlaxoSmithKline Plc - Key news
Exhibits113: GlaxoSmithKline Plc - Key offerings
Exhibits114: GlaxoSmithKline Plc - Segment focus
Exhibits115: Medicago Inc - Overview
Exhibits116: Medicago Inc - Product / Service
Exhibits117: Medicago Inc - Key offerings
Exhibits118: Novavax Inc. - Overview
Exhibits119: Novavax Inc. - Product / Service
Exhibits120: Novavax Inc. - Key offerings
Exhibits121: Sanofi - Overview
Exhibits122: Sanofi - Business segments
Exhibits123: Sanofi - Key news
Exhibits124: Sanofi - Key offerings
Exhibits125: Sanofi - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations